The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pharmacokinetics Market Research Report 2024
Synopsis
Pharmacokinetics is a branch of pharmacology dedicated to determining the fate of substances administered to a living organism.
The global Pharmacokinetics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharmacokinetics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmacokinetics.
Report Scope
The Pharmacokinetics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmacokinetics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmacokinetics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Charles River Laboratories
Covance
Cyprotex
Drumetix Laboratories
Eurofins Scientific
GVK Biosciences
LGC
Parexel
Pharmoptima
TCG Lifesciences
Segment by Type
Noncompartmental Methods
Compartmental Methods
Segment by Application
Oncology
Cardiovascular Diseases
Infectious Diseases
Autoimmune Diseases
Respiratory Disorders
Neurological Disorders
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmacokinetics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Pharmacokinetics is a branch of pharmacology dedicated to determining the fate of substances administered to a living organism.
The global Pharmacokinetics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharmacokinetics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmacokinetics.
Report Scope
The Pharmacokinetics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmacokinetics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmacokinetics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Charles River Laboratories
Covance
Cyprotex
Drumetix Laboratories
Eurofins Scientific
GVK Biosciences
LGC
Parexel
Pharmoptima
TCG Lifesciences
Segment by Type
Noncompartmental Methods
Compartmental Methods
Segment by Application
Oncology
Cardiovascular Diseases
Infectious Diseases
Autoimmune Diseases
Respiratory Disorders
Neurological Disorders
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmacokinetics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmacokinetics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Noncompartmental Methods
1.2.3 Compartmental Methods
1.3 Market by Application
1.3.1 Global Pharmacokinetics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Oncology
1.3.3 Cardiovascular Diseases
1.3.4 Infectious Diseases
1.3.5 Autoimmune Diseases
1.3.6 Respiratory Disorders
1.3.7 Neurological Disorders
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmacokinetics Market Perspective (2019-2030)
2.2 Pharmacokinetics Growth Trends by Region
2.2.1 Global Pharmacokinetics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pharmacokinetics Historic Market Size by Region (2019-2024)
2.2.3 Pharmacokinetics Forecasted Market Size by Region (2025-2030)
2.3 Pharmacokinetics Market Dynamics
2.3.1 Pharmacokinetics Industry Trends
2.3.2 Pharmacokinetics Market Drivers
2.3.3 Pharmacokinetics Market Challenges
2.3.4 Pharmacokinetics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmacokinetics Players by Revenue
3.1.1 Global Top Pharmacokinetics Players by Revenue (2019-2024)
3.1.2 Global Pharmacokinetics Revenue Market Share by Players (2019-2024)
3.2 Global Pharmacokinetics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pharmacokinetics Revenue
3.4 Global Pharmacokinetics Market Concentration Ratio
3.4.1 Global Pharmacokinetics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmacokinetics Revenue in 2023
3.5 Pharmacokinetics Key Players Head office and Area Served
3.6 Key Players Pharmacokinetics Product Solution and Service
3.7 Date of Enter into Pharmacokinetics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmacokinetics Breakdown Data by Type
4.1 Global Pharmacokinetics Historic Market Size by Type (2019-2024)
4.2 Global Pharmacokinetics Forecasted Market Size by Type (2025-2030)
5 Pharmacokinetics Breakdown Data by Application
5.1 Global Pharmacokinetics Historic Market Size by Application (2019-2024)
5.2 Global Pharmacokinetics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pharmacokinetics Market Size (2019-2030)
6.2 North America Pharmacokinetics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pharmacokinetics Market Size by Country (2019-2024)
6.4 North America Pharmacokinetics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmacokinetics Market Size (2019-2030)
7.2 Europe Pharmacokinetics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pharmacokinetics Market Size by Country (2019-2024)
7.4 Europe Pharmacokinetics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmacokinetics Market Size (2019-2030)
8.2 Asia-Pacific Pharmacokinetics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pharmacokinetics Market Size by Region (2019-2024)
8.4 Asia-Pacific Pharmacokinetics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmacokinetics Market Size (2019-2030)
9.2 Latin America Pharmacokinetics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pharmacokinetics Market Size by Country (2019-2024)
9.4 Latin America Pharmacokinetics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmacokinetics Market Size (2019-2030)
10.2 Middle East & Africa Pharmacokinetics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pharmacokinetics Market Size by Country (2019-2024)
10.4 Middle East & Africa Pharmacokinetics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River Laboratories
11.1.1 Charles River Laboratories Company Detail
11.1.2 Charles River Laboratories Business Overview
11.1.3 Charles River Laboratories Pharmacokinetics Introduction
11.1.4 Charles River Laboratories Revenue in Pharmacokinetics Business (2019-2024)
11.1.5 Charles River Laboratories Recent Development
11.2 Covance
11.2.1 Covance Company Detail
11.2.2 Covance Business Overview
11.2.3 Covance Pharmacokinetics Introduction
11.2.4 Covance Revenue in Pharmacokinetics Business (2019-2024)
11.2.5 Covance Recent Development
11.3 Cyprotex
11.3.1 Cyprotex Company Detail
11.3.2 Cyprotex Business Overview
11.3.3 Cyprotex Pharmacokinetics Introduction
11.3.4 Cyprotex Revenue in Pharmacokinetics Business (2019-2024)
11.3.5 Cyprotex Recent Development
11.4 Drumetix Laboratories
11.4.1 Drumetix Laboratories Company Detail
11.4.2 Drumetix Laboratories Business Overview
11.4.3 Drumetix Laboratories Pharmacokinetics Introduction
11.4.4 Drumetix Laboratories Revenue in Pharmacokinetics Business (2019-2024)
11.4.5 Drumetix Laboratories Recent Development
11.5 Eurofins Scientific
11.5.1 Eurofins Scientific Company Detail
11.5.2 Eurofins Scientific Business Overview
11.5.3 Eurofins Scientific Pharmacokinetics Introduction
11.5.4 Eurofins Scientific Revenue in Pharmacokinetics Business (2019-2024)
11.5.5 Eurofins Scientific Recent Development
11.6 GVK Biosciences
11.6.1 GVK Biosciences Company Detail
11.6.2 GVK Biosciences Business Overview
11.6.3 GVK Biosciences Pharmacokinetics Introduction
11.6.4 GVK Biosciences Revenue in Pharmacokinetics Business (2019-2024)
11.6.5 GVK Biosciences Recent Development
11.7 LGC
11.7.1 LGC Company Detail
11.7.2 LGC Business Overview
11.7.3 LGC Pharmacokinetics Introduction
11.7.4 LGC Revenue in Pharmacokinetics Business (2019-2024)
11.7.5 LGC Recent Development
11.8 Parexel
11.8.1 Parexel Company Detail
11.8.2 Parexel Business Overview
11.8.3 Parexel Pharmacokinetics Introduction
11.8.4 Parexel Revenue in Pharmacokinetics Business (2019-2024)
11.8.5 Parexel Recent Development
11.9 Pharmoptima
11.9.1 Pharmoptima Company Detail
11.9.2 Pharmoptima Business Overview
11.9.3 Pharmoptima Pharmacokinetics Introduction
11.9.4 Pharmoptima Revenue in Pharmacokinetics Business (2019-2024)
11.9.5 Pharmoptima Recent Development
11.10 TCG Lifesciences
11.10.1 TCG Lifesciences Company Detail
11.10.2 TCG Lifesciences Business Overview
11.10.3 TCG Lifesciences Pharmacokinetics Introduction
11.10.4 TCG Lifesciences Revenue in Pharmacokinetics Business (2019-2024)
11.10.5 TCG Lifesciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
